United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-0896_994b09e4-1dac-4fb6-a9c7-b361a2e11c6b
- Product NDC
- 50090-0896
- Form
- CAPSULE
- Composition / generic term
- Gabapentin
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110129
- Source listing expiry
- 20271231
Source-listed ingredients
- GABAPENTIN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (50090-0896-0) · 50090-0896-0
- 30 CAPSULE in 1 BOTTLE (50090-0896-1) · 50090-0896-1
- 60 CAPSULE in 1 BOTTLE (50090-0896-2) · 50090-0896-2
- 120 CAPSULE in 1 BOTTLE (50090-0896-3) · 50090-0896-3
- 90 CAPSULE in 1 BOTTLE (50090-0896-4) · 50090-0896-4
- 240 CAPSULE in 1 BOTTLE (50090-0896-5) · 50090-0896-5
- 270 CAPSULE in 1 BOTTLE (50090-0896-6) · 50090-0896-6
- 15 CAPSULE in 1 BOTTLE (50090-0896-7) · 50090-0896-7
- 42 CAPSULE in 1 BOTTLE (50090-0896-8) · 50090-0896-8
- 14 CAPSULE in 1 BOTTLE (50090-0896-9) · 50090-0896-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →